Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Single Dose vs Short-Term Peri-Operative Cefazolin in the Prevention of Surgical Site Infection Following Orthognathic Surgery

NCT05852158 is registered in ClinicalTrials.gov with Abdul El-Rabbany as lead sponsor.

NCT NCT05852158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05852158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Single Dose vs Short-Term Peri-Operative Cefazolin in the Prevention of Surgical Site Infection Following Orthognathic Surgery
Lead sponsor
Abdul El-Rabbany
Phase
Phase 4
Overall status
Recruiting
Start date
January 9, 2024
Completion date
July 31, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

orthognathic surgical site infection